{
    "clinical_study": {
        "@rank": "24954", 
        "arm_group": [
            {
                "arm_group_label": "Rest + Steady-State Hyperglycemia", 
                "arm_group_type": "Experimental", 
                "description": "A T = -1 hours, a 1-hour period of rest will begin. At T = 0 h, an 8-hour period of hyperglycemia will begin. Steady-state hyperglycemia will be induced via a constant infusion rate of glucose."
            }, 
            {
                "arm_group_label": "Rest + Fluctuating Hyperglycemia", 
                "arm_group_type": "Experimental", 
                "description": "A T = -1 hours, a 1-hour period of rest will begin. At T = 0 h, an 8-hour period of hyperglycemia will begin. Fluctuating hyperglycemia will be induced via a variable infusion rate of glucose."
            }, 
            {
                "arm_group_label": "Exercise + Steady-State Hyperglycemia", 
                "arm_group_type": "Experimental", 
                "description": "A T = -1 hours, a 1-hour exercise bout will begin. At T = 0 h, an 8-hour period of hyperglycemia will begin. Steady-state hyperglycemia will be induced via a constant infusion rate of glucose."
            }, 
            {
                "arm_group_label": "Exercise + Fluctuating Hyperglycemia", 
                "arm_group_type": "Experimental", 
                "description": "A T = -1 hours, a 1-hour exercise bout will begin. At T = 0 h, an 8-hour period of hyperglycemia will begin. Fluctuating hyperglycemia will be induced via a variable infusion rate of glucose."
            }
        ], 
        "brief_summary": {
            "textblock": "The effects of exercise on glucotoxicity will be determined in healthy subjects.\n      Experimental hyperglycemia will be induced via a constant- or fluctuating-rate glucose\n      infusion to establish different patterns of glycemic variability. The outcomes of\n      hyperglycemia will be determined by measuring pancreatic endocrine function, insulin\n      sensitivity, endothelial function, and oxidative stress."
        }, 
        "brief_title": "Acute Exercise and Glucotoxicity", 
        "condition": [
            "Type 1 Diabetes", 
            "Type 2 Diabetes"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18-60 years old\n\n          -  BMI 20-35 kg/m2\n\n          -  Willingness to partake in an exercise bout\n\n        Exclusion Criteria:\n\n          -  Contraindication to strenuous exercise\n\n          -  Clinical signs of chronic pulmonary, renal, hepatic, hematological, intestinal, or\n             cardiovascular disease\n\n          -  Pregnancy\n\n          -  Smoking\n\n          -  Recent weight loss (>2kg in 6 months)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01771614", 
            "org_study_id": "Glucotox-2"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Exercise + Steady-State Hyperglycemia", 
                    "Exercise + Fluctuating Hyperglycemia"
                ], 
                "intervention_name": "Exercise", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Rest + Steady-State Hyperglycemia", 
                    "Rest + Fluctuating Hyperglycemia", 
                    "Exercise + Steady-State Hyperglycemia", 
                    "Exercise + Fluctuating Hyperglycemia"
                ], 
                "intervention_name": "Hyperglycemia", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Glucotoxicity", 
            "Exercise", 
            "Beta-cell function"
        ], 
        "lastchanged_date": "January 16, 2013", 
        "location": {
            "contact": {
                "email": "thomas.solomon@inflammation-metabolism.dk", 
                "last_name": "Thomas P Solomon, PhD", 
                "phone": "+4535457629"
            }, 
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "state": "Capital Region", 
                    "zip": "2100"
                }, 
                "name": "Rigshospitalet"
            }, 
            "investigator": [
                {
                    "last_name": "Thomas P Solomon, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Kristian Karstoft, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Sine H Knudsen, MSc", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "4", 
        "overall_contact": {
            "email": "thomas.solomon@inflammation-metabolism.dk", 
            "last_name": "Thomas P Solomon, PhD", 
            "phone": "+4535457629"
        }, 
        "overall_official": {
            "affiliation": "Rigshospitalet, Denmark", 
            "last_name": "Thomas P Solomon, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Denmark: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The plasma insulin, C-peptide, and glucagon responses to a 0.33 g/kg intravenous glucose tolerance test (IVGTT) will be measured. In each trial, the IVGTT will be performed at 0, 8 and 24 hours.", 
            "measure": "Pancreatic endocrine function", 
            "safety_issue": "No", 
            "time_frame": "0, 8, and 24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01771614"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Thomas Solomon", 
            "investigator_title": "Senior Researcher", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Insulin sensitivity will be measured during an IVGTT in each trial at 0, 8, and 24 hours.", 
                "measure": "Insulin sensitivity", 
                "safety_issue": "No", 
                "time_frame": "0, 8, and 24 hours"
            }, 
            {
                "description": "Blood flow and flow-mediated dilation by Doppler ultrasound will be measured in each trial at 0, 2, 4, 6, 8, and 24 hours", 
                "measure": "Endothelial function", 
                "safety_issue": "No", 
                "time_frame": "0, 2, 4, 6, 8, and 24 hours"
            }, 
            {
                "description": "Urine will be collected over the whole 24-hour period of each trial and 8-iso Prostaglandin F3\u03b1 will be measured.", 
                "measure": "Oxidative stress", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }
        ], 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rigshospitalet, Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}